Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06953024
What this trial is testing

Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test

Who this might be right for
HivSyphilis
Nova Scotia Health Authority 120
Testing effectiveness (Phase 2)Study completedNCT06799741
What this trial is testing

Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection

Who this might be right for
DENV-3 Controlled Human Infection Model
AbViro LLC 85
Post-approval studies (Phase 4)Study completedNCT00925288
What this trial is testing

Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers

Who this might be right for
Human Papillomavirus Infection
Johns Hopkins Bloomberg School of Public Health 200
Early research (Phase 1)Study completedNCT04429529
What this trial is testing

Safety of TY027, a Treatment for COVID-19, in Humans

Who this might be right for
Coronavirus Disease-2019 (COVID-19)
Tychan Pte Ltd. 32
Not applicableUnknownNCT02463942
What this trial is testing

Tick-borne Encephalitis and Positive Borrelial Antibodies

Who this might be right for
Tick-borne Encephalitis
University Medical Centre Ljubljana 100
Not applicableEnded earlyNCT00393224
What this trial is testing

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Who this might be right for
Nasopharyngeal Neoplasms
National Cancer Institute (NCI) 952
Early research (Phase 1)Study completedNCT02825797
What this trial is testing

3BNC117 and 10-1074 in HIV-infected Individuals

Who this might be right for
Human Immunodeficiency Virus (HIV)
Rockefeller University 34
Post-approval studies (Phase 4)Study completedNCT00161785
What this trial is testing

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

Who this might be right for
Tick-borne Encephalitis
Pfizer 340
Not applicableLooking for participantsNCT06716450
What this trial is testing

Multiplo Tp/HIV Self-Test

Who this might be right for
HIV InfectionSyphilis Infection
Unity Health Toronto 900
Not applicableUnknownNCT05561868
What this trial is testing

COVID-19 Antibody Responses in Cystic Fibrosis

Who this might be right for
Cystic FibrosisCOVID-19
Children's Health Ireland 70
Early research (Phase 1)Ended earlyNCT05135650
What this trial is testing

Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Fred Hutchinson Cancer Center 20
Early research (Phase 1)UnknownNCT04441918
What this trial is testing

Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects

Who this might be right for
COVID-19; and High Infection Risk of SARS-CoV-2
Shanghai Junshi Bioscience Co., Ltd. 40
Testing effectiveness (Phase 2)Ended earlyNCT05375760
What this trial is testing

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
AstraZeneca 251
Testing effectiveness (Phase 2)Study completedNCT04465890
What this trial is testing

A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Ascletis Pharmaceuticals Co., Ltd. 207
Not applicableEnded earlyNCT04432779
What this trial is testing

Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children

Who this might be right for
PregnancyCovid-19
Centre Hospitalier Universitaire Saint Pierre 1,362
Large-scale testing (Phase 3)Study completedNCT02707861
What this trial is testing

Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1

Who this might be right for
HIV
TaiMed Biologics Inc. 79
Large-scale testing (Phase 3)Study completedNCT02759354
What this trial is testing

Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)

Who this might be right for
Hepatitis BPertussis
MCM Vaccines B.V. 754
Not applicableStudy completedNCT03566966
What this trial is testing

Autoantibodies and Direct-acting Antivirals

Who this might be right for
Viral Hepatitis CTherapy Adverse Effect
University of Bari 191
Post-approval studies (Phase 4)UnknownNCT06184230
What this trial is testing

Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.

Who this might be right for
Hepatitis A
Best Healthcare Inc. 300
Not applicableStudy completedNCT02455375
What this trial is testing

Diagnostic of Puumala Virus Infection in France

Who this might be right for
Nephropathia EpidemicaHemorrhagic Fever With Renal Syndrome
Centre Hospitalier de Charleville-Mézières 179
Next Page